ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Alcohol"

  • 2021 American Transplant Congress

    A Shift in Paradigm: Phosphatidylethanol Testing to Monitor for and Address Alcohol Recidivism Following Liver Transplantation

    F. M. Nimri1, S. Naffouj1, F. Askar1, A. Singh2, H. Gonzalez2, S. Jafri2

    1Internal Medicine, Henry Ford Hospital, Detroit, MI, 2Gastroenterology, Henry Ford Hospital, Detroit, MI

    *Purpose: Phosphatidylethanol (PEth) is a phospholipid that forms in the presence of ethanol with a long half-life compared to other alcohol detection tests. PEth testing…
  • 2021 American Transplant Congress

    Recent Trends and Outcomes of Liver Transplantation for Non-alcoholic Steatohepatitis versus Alcohol Liver Disease in the United States: Obesity Might be Protective

    K. Okumura, I. Lee, H. Sogawa, G. Veillette, D. John, T. Diflo, R. Bodin, D. Wolf, S. Nishida

    Surgery, Westchester Medical Center/New York Medical College, Valhalla, NY

    *Purpose: Nonalcoholic steatohepatitis (NASH) and alcohol liver disease (ALD) are rapidly growing indications for liver transplantation (LT). The recent trends and outcomes in NASH and…
  • 2021 American Transplant Congress

    Systematic Implementation of Alcohol Screening Program Using Urine Ethyl Glucuronide Can Identify Post-transplant Alcohol Use and Aid Return to Sobriety in Liver Transplant Recipients

    N. Lim1, T. Leventhal1, M. Thomson1, M. Hassan1, J. Thompson1, S. Chinnakotla2, V. Kirchner2, T. Pruett1, R. Kandaswamy2, V. Humphreville2, A. Adams2, J. Lake1

    1Division of Gastroenterology, Hepatology and Nutrition, University of Minnesota, Minneapolis, MN, 2Division of Transplantation, University of Minnesota, Minneapolis, MN

    *Purpose: Rates of liver transplantation (LT) for alcohol-related liver disease (ALD) are increasing, particularly in patients with acute alcoholic hepatitis. Post-LT alcohol (ETOH) use has…
  • 2021 American Transplant Congress

    “A New Lease on Life”: Patient Perceptions After Early Liver Transplantation for Alcohol-Related Liver Disease

    R. Greenberg, G. Punchhi, H. Sung, K. Gianaris, M. Krach, K. Herrick-Reynolds, P. Chen, M. Levan, J. Garonzik Wang, A. Cameron

    Johns Hopkins, Baltimore, MD

    *Purpose: At some centers, alcohol-related liver disease (ARLD) patients, who are unlikely to survive six months without a liver transplant (LT), are selected to receive…
  • 2020 American Transplant Congress

    Perioperative Opioid Avoidance in Liver Transplant Recipients: Significant Reduction in Opioid Use Through a Multidiscplinary, Multimodal Approach

    H. Kutzler, R. Gannon, W. Nolan, L. Meisterling, M. Cech, D. Gleason, J. Uzl, C. Rochon, B. Maneckshana, O. Serrano, J. Riley, D. O'Sullivan, E. Urtasun-Sotil, M. Einstein, P. Sheiner

    Hartford Hospital, Hartford, CT

    *Purpose: Given the association between substance use disorder and risk of post-surgical opioid use disorder, we developed an opioid avoidance pathway (OAP) in adult liver…
  • 2020 American Transplant Congress

    Results of a Prospective Pilot Program for Transplantation of Patients with Alcohol-Related Liver Disease and Less Than 6 Months Abstinence

    J. Quance, L. Carrique, I. Sales, L. Lilly, M. Bhat, Z. Galvin, A. Tan, S. Abbey, J. Lynch, N. Selzner

    Multiorgan Transplant Institute, University of Toronto, Toronto, ON, Canada

    *Purpose: In Canada, 6 months of abstinence for those with alcohol-associated liver disease (ALD) is typically required prior to being listed for liver transplantation (LT).This…
  • 2020 American Transplant Congress

    Re-Establishing Abstinence after Alcohol Relapse after Early Transplant (LT) for Alcoholic Hepatitis (AH) Provides Survival Advantage

    J. Rice1, B. Lee2, G. Therapondos3, G. Im4, A. Lazar2, M. Lucey1, E. Weinberg5, H. Han6, H. Maddur7, M. Ghobrial8, C. Hsu9, O. Fix10, S. Eswaran11, K. Shetty12, N. Jakhete12, D. Victor8, D. Foley1, N. Mehta2, M. Rinella7, T. Schiano4, C. Mobley8, N. Terrault6

    1U of WI SMPH, Madison, WI, 2UCSF, San Francisco, CA, 3Oschner, New Orleans, LA, 4Mt Sinai, New York, NY, 5U Penn, Philadelphia, PA, 6USC, Los Angeles, CA, 7NW Univ, Chicago, IL, 8Houston Mdt, Houston, TX, 9GTown U, Washington, DC, 10Swed Med, Seattle, WA, 11Rush Med C, Chicago, IL, 12U of MD, Baltimore, MD

    *Purpose: Among the ACCELERATE-AH cohort: (i) Identify factors associated with re-established abstinence in patients with alcohol relapse after LT for alcoholic hepatitis (AH); (ii) Determine…
  • 2020 American Transplant Congress

    Comparison of One-Year Morbidity Following Liver Transplant for Acute Alcoholic Hepatitis vs. Alcoholic Cirrhosis

    O. M. Andacoglu1, U. Ozbek2, J. Liu3, C. Figueredo3, K. R. Chacko4, C. Tow4, J. F. Reinus4, M. Kinkhabwala1

    1Surgery, Montefiore Medical Center, Bronx, NY, 2Population Health Science and Policy, Icahn School of Medicine, Mount Sinai, New York, NY, 3Montefiore Medical Center, Bronx, NY, 4Medicine, Montefiore Medical Center, Bronx, NY

    *Purpose: Liver transplants (LT) for acute alcoholic hepatitis (AH) have become more common but there is limited data about outcomes of LT as therapy for…
  • 2020 American Transplant Congress

    Healthcare Utilization and Costs of Liver Transplantation for Alcoholic Hepatitis

    G. Im1, A. Vogel1, S. S. Florman2, S. Aqui3, L. Kim-Schluger1, T. Schiano1

    1Medicine, Liver Diseases, Recanati/Miller Transplantation Institute, Icahn School of Medicine at Mount Sinai, RMTI, New York, NY, 2Surgery, Recanati/Miller Transplantation Institute, Icahn School of Medicine at Mount Sinai, RMTI, New York, NY, 3Recanati/Miller Transplantation Institute, Icahn School of Medicine at Mount Sinai, RMTI, New York, NY

    *Purpose: To determine the healthcare utilization and costs of a liver transplantation (LT) for severe alcoholic hepatitis (AH) program.*Methods: We performed a retrospective healthcare utilization…
  • 2020 American Transplant Congress

    IM Naltrexone Post Liver Transplant for Alcoholic Hepatitis Patients to Prevent Relapse

    A. Flecha

    Transplant Surgery, Montefiore Medical Center, Bronx, NY

    *Purpose: The number of patients requiring liver transplants due to Hepatitis C Virus is declining due to the new treatment options, and the growing number…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 7
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences